Additionally, sequencing the promoter region, particularly the TATAA box, is essential because the presence of a UGT1A1 polymorphism such as UGT1A128 (associated with GS) can further reduce the expression of the enzyme, exacerbating hyperbilirubinemia [1]. This evidence concerns the gene UGT1A1 and Gerstmann syndrome.